2022
DOI: 10.1038/s41375-022-01549-6
|View full text |Cite|
|
Sign up to set email alerts
|

Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 47 publications
1
3
0
Order By: Relevance
“…Laboratory data have shown increased interferon-producing T cells, in the marrow of AA patients. More recently, the "escape mechanisms of stem cells from an autoimmune T cells attack" has been strongly suggested by the following results in AA patients: loss of heterozygosity of chromosome arm 6p [26], loss of HLA DR 15 [27], and structural homology of HLA evolutionary divergence, defining patterns of autoreactivity [26]. This in vitro evidence further supports the autoimmune pathogenesis already suggested to explain the expansion of GPI negative cells.…”
Section: Clonal Haematopoiesis and Malignancysupporting
confidence: 71%
See 3 more Smart Citations
“…Laboratory data have shown increased interferon-producing T cells, in the marrow of AA patients. More recently, the "escape mechanisms of stem cells from an autoimmune T cells attack" has been strongly suggested by the following results in AA patients: loss of heterozygosity of chromosome arm 6p [26], loss of HLA DR 15 [27], and structural homology of HLA evolutionary divergence, defining patterns of autoreactivity [26]. This in vitro evidence further supports the autoimmune pathogenesis already suggested to explain the expansion of GPI negative cells.…”
Section: Clonal Haematopoiesis and Malignancysupporting
confidence: 71%
“…In a retrospective analysis, published in 1994 [32], second HCT for graft rejection had a poor outcome of 33%, but appeared to improve in another retrospective report in 2015 [33]. In general, SAA response to treatment is dependent on the age of the patient and the severity of the disease [26]. Haematopietic stem cell transplants (HSCT) from a matched sibling donor is currently the gold standard for SAA patients < 50 years of age.…”
Section: Saa Treatmentmentioning
confidence: 99%
See 2 more Smart Citations